Cyclo Therapeutics, Inc. (CYTH)
NASDAQ: CYTH · IEX Real-Time Price · USD
1.290
0.00 (0.00%)
At close: Apr 25, 2024, 2:28 PM
1.270
-0.020 (-1.55%)
After-hours: Apr 25, 2024, 4:36 PM EDT
Cyclo Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Cyclo Therapeutics stock have an average target of 3.30, with a low estimate of 2.60 and a high estimate of 4.00. The average target predicts an increase of 155.81% from the current stock price of 1.29.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CYTH stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 |
| Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Initiates $2.6 | Strong Buy | Initiates | $2.6 | +101.55% | Apr 22, 2024 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $4 | Hold → Strong Buy | Upgrades | $4 | +210.08% | Sep 27, 2023 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 21, 2023 |
Financial Forecast
Revenue This Year
3.37M
from 1.08M
Increased by 212.89%
Revenue Next Year
30.21M
from 3.37M
Increased by 797.06%
EPS This Year
-1.07
from -1.23
EPS Next Year
-0.29
from -1.07
Revenue Forecast
| Revenue | 2024 | 2025 |
|---|---|---|
| High | 3.5M | 31.1M |
| Avg | 3.4M | 30.2M |
| Low | 3.2M | 29.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 |
|---|---|---|
| High | 222.1% | 823.5% |
| Avg | 212.9% | 797.1% |
| Low | 200.6% | 761.9% |
EPS Forecast
| EPS | 2024 | 2025 |
|---|---|---|
| High | -1.10 | -0.29 |
| Avg | -1.07 | -0.29 |
| Low | -1.03 | -0.27 |
EPS Growth
| EPS Growth | 2024 | 2025 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.